|
ZKSCAN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.23020499237714E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.10900000083581E-09 |
| Normal-vs-Stage2 |
1.399100E-03 |
| Normal-vs-Stage3 |
9.23849996503634E-10 |
| Normal-vs-Stage4 |
9.82410042205117E-10 |
| Stage1-vs-Stage2 |
1.542600E-01 |
| Stage1-vs-Stage3 |
2.134800E-01 |
| Stage1-vs-Stage4 |
1.029980E-02 |
| Stage2-vs-Stage3 |
2.380400E-02 |
| Stage2-vs-Stage4 |
2.063700E-03 |
| Stage3-vs-Stage4 |
2.049000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11380024595087E-10 |
| Normal-vs-AfricanAmerican |
3.553700E-02 |
| Normal-vs-Asian |
3.6909000000751E-07 |
| Caucasian-vs-AfricanAmerican |
5.878400E-02 |
| Caucasian-vs-Asian |
8.684400E-01 |
| AfricanAmerican-vs-Asian |
8.351700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37069999794903E-08 |
| Normal-vs-Female |
1.47519996218648E-10 |
| Male-vs-Female |
8.008600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.08649999686872E-09 |
| Normal-vs-Age(41-60Yrs) |
5.85360004912161E-09 |
| Normal-vs-Age(61-80Yrs) |
7.1451999983374E-08 |
| Normal-vs-Age(81-100Yrs) |
4.02980000002717E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.577600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.590400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.178640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.288200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.674580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.276000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.563800000006E-05 |
| Classical-VS-Follicular |
4.370000E-01 |
| Classical-VS-Other |
4.002400E-01 |
| Classical-VS-Normal |
5.90869997374455E-09 |
| Tall-VS-Follicular |
7.143900E-03 |
| Tall-VS-Other |
6.626800E-01 |
| Tall-VS-Normal |
6.11539707762176E-11 |
| Follicular-VS-Other |
6.046200E-01 |
| Follicular-VS-Normal |
5.44329999963011E-07 |
| Other-VS-Normal |
1.032430E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62300000106086E-08 |
| Normal-vs-N1 |
1.10929999630471E-08 |
| N0-vs-N1 |
4.195600E-02 |
|
|
